Precipio Launchess New HemeScreen Panel for Blood Cancer Test; Stock Jumps
01:03 PM EDT, 05/10/2021 (MT Newswires) -- Precipio (PRPO) said Monday it has launched a new HemeScreen panel to test for acute myeloid leukemia, a type of blood cancer, that can yield results about four hours later.
The company said it expects the panel to increase revenue to its oncology physician office laboratories by about 10%, and to similarly raise its revenue from existing and future oncology physician office laboratories and other laboratory customers who incorporate this panel into their operations.
The stock jumped 36% in afternoon trading.
Price: 5.18, Change: +1.34, Percent Change: +34.92